Brief: Peptonic: Clinical Study With VagiVital Shows Significant Symptom Relief

Peptonic Medical AB

04/09/2020 08:48

Sept 4 (Reuters) - Peptonic Medical AB  PMED.TE :
    * SAID ON THURSDAY CLINICAL STUDY WITH VAGIVITAL SHOWS
SIGNIFICANT
SYMPTOM RELIEF IN WOMEN UNDERGOING CANCER TREATMENT AND
SUFFERING FROM VAGINAL ATROPHY
    * RESULTS SHOW STRONG RELIEF OF THE MOST BOTHERSOME SYMPTOMS
SUCH
AS VAGINAL DRYNESS, VAGINAL ITCHING AND PAIN DURING SEXUAL
INTERCOURSE (DYSPAREUNIA)
    * ALL IMPROVEMENTS WERE STATISTICALLY SIGNIFICANT (P<0.001)
AND
THE MAGNITUDE OF THE IMPROVEMENTS WERE AT LEAST ON THE SAME
LEVEL AS SEEN IN PREVIOUS CLINICAL STUDIES WITH VAGIVITAL

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkrh8dFg
    
 Further company coverage:  PMED.TE  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))